An Iron-chelating Agent Improved the Cardiac Function in a Patient with Severe Heart Failure Due to Hereditary...

Area of Science:

• Cardiology
• Genetics
• Hematology

Background:

• Heart failure is a complex condition with various underlying causes.
• Hereditary hemochromatosis is a genetic disorder characterized by excessive iron absorption and storage.

Observation:

• A young man presented with severe, progressive heart failure unresponsive to standard treatments.
• Endomyocardial biopsy revealed significant iron deposition within the heart muscle cells (myocytes).

Findings:

• The patient was diagnosed with hereditary hemochromatosis.
• Treatment with an iron-chelating agent, alongside conventional heart failure therapy, led to clinical improvement.

Implications:

• Hereditary hemochromatosis should be considered in the differential diagnosis of heart failure, particularly with severe biventricular dysfunction.
• Early diagnosis and iron chelation therapy may improve outcomes for heart failure patients with hereditary hemochromatosis.